FDA NDC Directory · JSON-LD · Markdown

CLORAZEPATE DIPOTASSIUM

NDC 13107-282 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAurolife Pharma LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA071858
Dosage form / routeTABLET · ORAL
Active ingredientsCLORAZEPATE DIPOTASSIUM (3.75 mg/1)
Marketing started20230923
Package count2

External sources

Source: openFDA. Public-domain (CC0).